[{"id":6285,"regimens":[{"id":12111,"duration":{"id":6109,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8971,"name":"Meropenem","url":"cure-api2.ncats.io/v1/drugs/8971","rxNorm_id":null,"notes":null},"use_drug":[{"id":9442,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12111},{"id":9443,"answer":"In a novel combination with another drug","answer_other":"","regimen":12111}],"created":"2020-10-21T15:37:02.053713Z","updated":"2020-10-21T15:50:49.308037Z","dose":"1 gram","frequency":"TID","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12112,"duration":{"id":6110,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8711,"name":"Levofloxacin","url":"cure-api2.ncats.io/v1/drugs/8711","rxNorm_id":null,"notes":null},"use_drug":[{"id":9444,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12112},{"id":9445,"answer":"In a novel combination with another drug","answer_other":"","regimen":12112}],"created":"2020-10-21T15:37:02.061422Z","updated":"2020-10-21T15:50:49.314457Z","dose":"750mg","frequency":"QD","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12113,"duration":{"id":6111,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8745,"name":"Linezolid","url":"cure-api2.ncats.io/v1/drugs/8745","rxNorm_id":null,"notes":null},"use_drug":[{"id":9446,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12113},{"id":9447,"answer":"In a novel combination with another drug","answer_other":"","regimen":12113}],"created":"2020-10-21T15:37:02.067716Z","updated":"2020-10-21T15:50:49.320703Z","dose":"600mg","frequency":"BID","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12114,"duration":{"id":6112,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":9448,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12114},{"id":9449,"answer":"In a novel combination with another drug","answer_other":"","regimen":12114}],"created":"2020-10-21T15:37:02.073839Z","updated":"2020-10-21T15:50:49.326344Z","dose":"400 mg BID for first day, then 200mg BID for following days","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12115,"duration":{"id":6113,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6067,"name":"Atazanavir","url":"cure-api2.ncats.io/v1/drugs/6067","rxNorm_id":null,"notes":null},"use_drug":[{"id":9450,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12115},{"id":9451,"answer":"In a novel combination with another drug","answer_other":"","regimen":12115}],"created":"2020-10-21T15:37:02.080253Z","updated":"2020-10-21T15:50:49.332148Z","dose":"400mg","frequency":"QD","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12116,"duration":{"id":6114,"approximate_duration":"3 days","dates_unknown":true},"drug":{"id":8412,"name":"Immunoglobulins, Intravenous","url":"cure-api2.ncats.io/v1/drugs/8412","rxNorm_id":null,"notes":null},"use_drug":[{"id":9452,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12116},{"id":9453,"answer":"In a novel combination with another drug","answer_other":"","regimen":12116}],"created":"2020-10-21T15:37:02.086722Z","updated":"2020-10-21T15:50:49.337629Z","dose":"25 grams/day","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Patient was intubated before the start of treatment.","comments":null,"report":6285},{"id":12117,"duration":{"id":6115,"approximate_duration":"6 days","dates_unknown":true},"drug":{"id":9077,"name":"Methylprednisolone","url":"cure-api2.ncats.io/v1/drugs/9077","rxNorm_id":null,"notes":null},"use_drug":[{"id":9454,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12117}],"created":"2020-10-21T15:37:02.092780Z","updated":"2020-10-21T15:50:49.343019Z","dose":"500mg","frequency":"QD","route":"IV","severity":"ICU/Critical Care","severity_detail":"Treatment was given for para-infectious encephalitis associated with COVID-19; after treatment the diplopia resolved and she regained complete consciousness.","comments":null,"report":6285}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8271,"answer":"Clinical assessment","answer_other":"","report":6285},{"id":8272,"answer":"Imaging","answer_other":"","report":6285},{"id":8273,"answer":"Serology","answer_other":"","report":6285},{"id":8274,"answer":"PCR","answer_other":"","report":6285}],"how_diagnosis":[{"id":14075,"answer":"Serology","answer_other":"","report":6285},{"id":14076,"answer":"PCR","answer_other":"","report":6285},{"id":14077,"answer":"Clinical assessment","answer_other":"","report":6285},{"id":14078,"answer":"Imaging","answer_other":"","report":6285}],"author_username":"Kate Borkowski","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4347,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6285}],"adverse_event_outcome":[{"id":82,"answer":"Required Intervention to Prevent Permanent Impairment/Damage","report":6285},{"id":81,"answer":"Non-Serious Medical Event","report":6285}],"is_author":false,"cross_linked_diseases":[{"id":397,"name":"Encephalitis"},{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-10-21T15:34:07.153470Z","updated":"2020-10-21T15:50:49.299694Z","title":"Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32464585,"doi":"10.1016/j.msard.2020.102216","article_url":"https://pubmed.ncbi.nlm.nih.gov/32464585/","pub_year":2020,"published_authors":"Afshar H\r\nYassin Z\r\nKalantari S\r\nAloosh O\r\nLotfi T\r\nMoghaddasi M\r\nSadeghipour A\r\nEmamikhah M","article_author_email":"maziar.emamikhah@yahoo.com","journal":"Multiple sclerosis and related disorders","abstract":"The new severe acute respiratory syndrome- coronavirus 2 is reported to affect the nervous system. Among the reports of the various neurological manifestations, there are a few documented specific processes to explain the neurological signs. We report a para-infectious encephalitis patient with clinical, laboratory, and imaging findings during evolution and convalescence phase of coronavirus infection. This comprehensive overview can illuminate the natural history of similar cases. As the two previously reported cases of encephalitis associated with this virus were not widely discussed regarding the treatment, we share our successful approach and add some recommendations about this new and scarce entity.          \r\n        Keywords:      \r\n                  COVID-19; SARS-Cov-2; encephalitis; immunotherapy; natural history; post-infectious.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Female","ethnicity":null,"country_contracted":"Iran, Islamic Republic of","country_treated":"Iran, Islamic Republic of","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"RT-polymerase chain reaction (PCR) of a nasopharyngeal swab was negative for SARS-CoV 2 yet she was admitted with a diagnosis of Covid-19, based on clinical history (She had prolonged exposure to a covid-19 patient for prior 2 weeks) and chest CT scan findings. Results of SARS-CoV 2 serology tests taken during admission became available after discharge and were positive for both IgG and IgM.\r\n\r\nAlso, the patient experienced an episode of self-limited generalized tonic-clonic seizure (GTCS) on the following day after admission (day 11) treated with intravenous (IV) levetiracetam 500 mg bid. She experienced another episode of GTCS on the same day, managed with increment in levetiracetam dosage (500 mg tid).","drug_treatment_features":"","have_adverse_events":true,"adverse_events":"After administration of a total 250 g (3 g/kg) IVIg, it was stopped due to occurrence of headaches that seemed related to drug infusion. After discontinuation of IVIg, the headaches resolved completely and due to presence of diplopia and drowsiness treatment was then continued with methylprednisolone (500 mg/day for six days), which led to complete resolution of neurological symptoms.","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6067,8342,8412,8711,8745,8971,9077]}]